<?xml version="1.0" encoding="UTF-8"?>
<ref id="B124-viruses-12-00339">
 <label>124.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Engeland</surname>
    <given-names>C.E.</given-names>
   </name>
   <name>
    <surname>Grossardt</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Veinalde</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Bossow</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lutz</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Kaufmann</surname>
    <given-names>J.K.</given-names>
   </name>
   <name>
    <surname>Shevchenko</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Umansky</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Nettelbeck</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Weichert</surname>
    <given-names>W.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy</article-title>
  <source>Mol. Ther.</source>
  <year>2014</year>
  <volume>22</volume>
  <fpage>1949</fpage>
  <lpage>1959</lpage>
  <pub-id pub-id-type="doi">10.1038/mt.2014.160</pub-id>
  <pub-id pub-id-type="pmid">25156126</pub-id>
 </element-citation>
</ref>
